arBtrage CAPITALIZING MARKETS checking… Sign in

Immunome, Inc.

IMNM Health Care Biotechnology: Pharmaceutical Preparations
$18.58
▼ -5.6% Today
as of Jun 7, 07:18 ET
Last 30 days -21.64% Apr 28 → Jun 05
$18.17 $19.66 $21.14 $22.63 $24.12 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$19.56
High
$19.80
Low
$18.56
Volume
$895,610
Avg Vol
$1M
Mkt Cap
$2.6B
P/E (TTM)
Beta
52w High
$27.65
52w Low
$7.96
Div Yield
Shares Out
$113M

Overview

52-week range
$7.96
$28
54% of range
Avg surprise (last 2)
+20.6%
Avg reaction (last 2)
+2.5%
50% positive
Latest IV / EM
103%
EM ±14.3% · $19 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.51$-1.97$-1.43$-0.90$-0.36 Actual $-0.46Actual $-0.36Actual $-2.51Actual $-0.60Actual $-0.78Actual $-0.52Est $-0.66Actual $-0.50Actual $-0.65Actual $-0.48Est $-0.60 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$-42M$-27M$-11M$4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.48 $-0.60 +20.0% +7.7% -1.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.65 financials
Mon Jun 30, 2025Jun 2025 $-0.50 financials
Mon May 12, 2025Mar/2025 $-0.52 $-0.66 +21.2% +6.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.78 financials
Sun Jun 30, 2024Jun 2024 $-0.60 financials
Sun Mar 31, 2024Mar 2024 $-2.51 financials
Sat Sep 30, 2023Sep 2023 $-0.36 financials
Fri Jun 30, 2023Jun 2023 $-0.46 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0$4M$3M$3M$2M
Cost of revenue
Gross profit
Operating income$-59M$-60M$-46M$-45M$-51M$-40M
Net income$-54M$-57M$-43M$-42M$-47M$-36M
EPS (diluted)$-0.48$-0.65$-0.50$-0.52$-0.78$-0.60

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$583M$653M$273M$144M$258M$143M$156M$165M
Inventory
Total current assets$594M$661M$280M$277M$323M$221M$244M$284M
Total assets$620M$683M$299M$296M$343M$240M$257M$296M
Long-term debt
Total liabilities$31M$49M$35M$27M$36M$59M$42M$42M
Total equity$589M$634M$264M$269M$307M$181M$215M$254M

Implied volatility — last 90 days

97%100%102%105%107% Jun 07 — IV 103% · EM ±14.3%

Sector peers